Similar articles for PMID: 18720264

Year	Number of Results
1979	1
1982	1
1992	1
2000	2
2001	5
2002	8
2003	11
2004	11
2005	29
2006	30
2007	40
2008	70
2009	44
2010	14
2011	20
2012	21
2013	16
2014	10
2015	8
2016	7
2017	4
2018	4
2019	3
2020	4
2021	6
2022	1
2024	0

1

Multiple sclerosis following etanercept treatment for ankylosing spondylitis.

Pfueller CF, Seipelt E, Zipp F, Paul F. Pfueller CF, et al. Scand J Rheumatol. 2008 Sep-Oct;37(5):397-9. doi: 10.1080/03009740802136164. Scand J Rheumatol. 2008. PMID: 18720264 No abstract available.

2

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.

Gorman JD, Sack KE, Davis JC Jr. Gorman JD, et al. N Engl J Med. 2002 May 2;346(18):1349-56. doi: 10.1056/NEJMoa012664. N Engl J Med. 2002. PMID: 11986408 Free article. Clinical Trial.

3

New-onset psoriasis associated with etanercept therapy.

Chen LA, Su LH, Chang YJ, Hsu YL, Tsai TH. Chen LA, et al. J Dermatol. 2010 Apr;37(4):378-80. doi: 10.1111/j.1346-8138.2010.00789.x. J Dermatol. 2010. PMID: 20507411 Review. No abstract available.

4

Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.

Cantini F, Niccoli L, Benucci M, Chindamo D, Nannini C, Olivieri I, Padula A, Salvarani C. Cantini F, et al. Arthritis Rheum. 2006 Oct 15;55(5):812-6. doi: 10.1002/art.22236. Arthritis Rheum. 2006. PMID: 17013842 Free article. Clinical Trial. No abstract available.

5

Uveitis and tumour necrosis factor blockade in ankylosing spondylitis.

Coates LC, McGonagle DG, Bennett AN, Emery P, Marzo-Ortega H. Coates LC, et al. Ann Rheum Dis. 2008 May;67(5):729-30. doi: 10.1136/ard.2007.077370. Ann Rheum Dis. 2008. PMID: 18408116 No abstract available.

6

BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.

Keat A, Barkham N, Bhalla A, Gaffney K, Marzo-Ortega H, Paul S, Rogers F, Somerville M, Sturrock R, Wordsworth P; BSR Standards, Guidelines and Audit Working group. Keat A, et al. Rheumatology (Oxford). 2005 Jul;44(7):939-47. doi: 10.1093/rheumatology/keh669. Epub 2005 May 18. Rheumatology (Oxford). 2005. PMID: 15901904 No abstract available.

7

Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action.

Haraoui B, Krelenbaum M. Haraoui B, et al. Semin Arthritis Rheum. 2009 Dec;39(3):176-81. doi: 10.1016/j.semarthrit.2008.06.004. Epub 2008 Aug 15. Semin Arthritis Rheum. 2009. PMID: 18706681

8

Acute myelogenous leukaemia following etanercept therapy.

Bakland G, Nossent H. Bakland G, et al. Rheumatology (Oxford). 2003 Jul;42(7):900-1. doi: 10.1093/rheumatology/keg128. Rheumatology (Oxford). 2003. PMID: 12826706 No abstract available.

9

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.

Brandt J, Listing J, Haibel H, Sörensen H, Schwebig A, Rudwaleit M, Sieper J, Braun J. Brandt J, et al. Rheumatology (Oxford). 2005 Mar;44(3):342-8. doi: 10.1093/rheumatology/keh475. Epub 2004 Nov 23. Rheumatology (Oxford). 2005. PMID: 15561737 Clinical Trial.

10

Etanercept in adult patients with early onset ankylosing spondylitis.

Inman RD, Clegg DO, Davis JC, Whitmore JB, Solinger A. Inman RD, et al. J Rheumatol. 2006 Aug;33(8):1634-6. J Rheumatol. 2006. PMID: 16881118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

327 results

Results by year